Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
17
|
| pubmed:dateCreated |
1992-2-3
|
| pubmed:abstractText |
The Authors report their personal experience of surgical treatment following neo-adjuvant therapy in NSCLC (III a N2) in order to assess: 1) the feasibility and safety of surgical treatment following major responses to neoadjuvant chemotherapy; 2) the sectile rate; and 3) the survival rate. Preliminary results show that: 1) chemotherapy using cisplatin and VP-16 gives a high rate of major responses in these patients; 2) surgery is feasible; 3) there is high radical sectile rate; 4) further research is needed to obtain statistical significance.
|
| pubmed:language |
ita
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Sep
|
| pubmed:issn |
0026-4733
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
15
|
| pubmed:volume |
46
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
N
|
| pubmed:pagination |
879-84
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:1661867-Aged,
pubmed-meshheading:1661867-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:1661867-Chemotherapy, Adjuvant,
pubmed-meshheading:1661867-Combined Modality Therapy,
pubmed-meshheading:1661867-Feasibility Studies,
pubmed-meshheading:1661867-Female,
pubmed-meshheading:1661867-Humans,
pubmed-meshheading:1661867-Lung Neoplasms,
pubmed-meshheading:1661867-Male,
pubmed-meshheading:1661867-Middle Aged,
pubmed-meshheading:1661867-Risk Factors,
pubmed-meshheading:1661867-Survival Analysis
|
| pubmed:year |
1991
|
| pubmed:articleTitle |
[Surgery after neo-adjuvant therapy of non-small cell lung cancer. Preliminary results].
|
| pubmed:affiliation |
Unità di Chirurgia, Ospedale R. Silvestrini, Perugia.
|
| pubmed:publicationType |
Journal Article,
English Abstract
|